Dave Weiner

Stock Analyst at Piper Sandler

(1.49)

# 3,743

Out of 5,182 analysts

9

Total ratings

50%

Success rate

0.43%

Average return

Main Sectors:

Healthcare Consumer Discretionary

Top Industries:

Diagnostics & Research Apparel Retail

Stocks Rated by Dave Weiner

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MYGN Myriad Genetics	Maintains: Overweight	$9 → $8.5	$4.84	+75.62%	4	Nov 11, 2025
	LULU lululemon athletica inc.	Upgrades: Buy	n/a	$142.39	-	5	Dec 14, 2017

Myriad Genetics

Nov 11, 2025

Maintains: Overweight

Price Target: $9 → $8.5

Current: $4.84

Upside: +75.62%

lululemon athletica inc.

Dec 14, 2017

Upgrades: Buy

Price Target: n/a

Current: $142.39

Upside: -